When the Courts Actually Work
The One Tweet That Perfectly Summarizes Why Thomas Massie Lost Last Night
You're Not Going to Believe What This Graham Platner Adviser Said About His...
Trump's Paxton Endorsement Triggered a Total Meltdown Among Panican GOP Members
CNN Analyst Not Shocked That Thomas Massie Got Throttled in His Primary For...
The Knicks Had an O.1 Percent Chance of Winning This Game...and Then History...
We Have Some HUGE News About South Carolina's Redistricting Effort
Supporters of the Dignity Act Are Playing the Religious Card, and It's Backfiring...
Guess Why the Cambridge City Council Ended Its Shotspotter Program
Jacob Frey Admits What We Knew All Along About Anti-ICE Riots
Did Hakeem Jeffries Really Just Say This About Trump Voters?
Democrat Senate Hopeful Graham Platner Admitted Taliban-Compromised Network Was Used for ‘...
The Wonderful, Loving Left
When 'Mostly Peaceful' Crosses Into Conspiracy: The DOJ Finally Reads the Riot Act
Spanberger, Meador, and the SPLC
Tipsheet

Media Outlets Openly Report That the FDA's Latest Decision Was Political

Media Outlets Openly Report That the FDA's Latest Decision Was Political

The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill in the U.S.

In early 2024, Perrigo’s once-a-day Opill, a progestin-only pill, will be available at drug stores, supermarkets, and online.

Advertisement

“Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, on Thursday. “When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy.”

There is no age restriction on the pill, despite concerns over correct usage and possible health hazards associated with it.

Seventeen advisers to the FDA voted unanimously in May to make Opill available over the counter despite concerns the agency raised about data Perrigo submitted with its application, including a study showing that many participants reported taking more pills than they were dispensed. The company said it couldn’t explain the discrepancy.

The agency questioned whether younger people and people with limited literacy could follow the dosing directions and said researchers likely used methods that exaggerated positive results. Perrigo said standards met or exceeded those used in other studies exploring over-the-counter drug adherence. (WSJ)

Kristan Hawkins of Students for Life said the news should mean pro-choice advocates won’t need abortions anymore, according to their own arguments. 

Advertisement

Related:

FDA

Others pointed out that media reports are not hiding the fact that it was a political decision. 

Health experts, citing the pill’s lengthy record of safety and effectiveness, have pushed for a nonprescription pill for years, but their campaign took on new urgency after the Supreme Court last year struck down the fundamental right to abortion established by Roe v. Wade. (WaPo)

Since the Supreme Court overturned the national right to an abortion last year, the accessibility of contraception has become an increasingly urgent issue. (NYT)

Though the drug itself and the campaign for its approval go back decades, pressure on the Biden administration to approve a hormonal over-the-counter birth control option increased after the fall of Roe v. Wade last year. (Politico)


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement